icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
 
 
 
Doravirine in Non-Inferior To Darunavir+Ritonavir in Phase 3 Treatment-Naive Trial at Week 48
 
 
  Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
 
WEBCAST: http://www.croiwebcasts.org/console/player/33382?mediaType=slideVideo&
 

0215171

0215172

0215173

0215174

0215175

0215176

0215177

0215178